LobbyingTransmedics lobbying by quarter
Transmedics TMDX's latest lobbying report covers Q2 2026, at $130K. The four quarters Q4 2025–Q3 2026 total $410K. Its first report covers Q4 2022; the issues it reports most are Health Issues and Medical/Disease Research/Clinical Labs.
TransmedicsTMDX
- Latest quarter
- No record
- Q3 2026 · 0 reports
- Last 12 months
- $410K
- Last 4 quarters
- vs last quarter
- −100.0%
- Q3 2026 against the quarter before
- First report
- Q4 2022
- The first quarter a report named it
Lobbying by quarter
| Quarter | Amount | Reports |
|---|---|---|
| Q4 2022 | $0 | 1 |
| Q1 2023 | $0 | 1 |
| Q2 2023 | $40K | 1 |
| Q3 2023 | $50K | 1 |
| Q4 2023 | $20K | 1 |
| Q1 2024 | $90K | 1 |
| Q2 2024 | $10K | 1 |
| Q3 2024 | $0 | 1 |
| Q4 2024 | $0 | 1 |
| Q1 2025 | $60K | 1 |
| Q2 2025 | $110K | 1 |
| Q3 2025 | $110K | 1 |
| Q4 2025 | $110K | 1 |
| Q1 2026 | $170K | 2 |
| Q2 2026 | $130K | 2 |
| Q3 2026 | $0 | 0 |
By issue
- Health issues$640K · 12 reports
- Medical research and clinical labs$260K · 2 reports
An issue's amount splits each report's amount equally over the issues the report lists.
Who was lobbied
- HOUSE OF REPRESENTATIVES12 reports
- Health Resources & Services Administration (HRSA)7 reports
- SENATE7 reports
- Centers For Medicare and Medicaid Services (CMS)4 reports
- Health & Human Services, Dept of (HHS)2 reports
Firms it paid
| Firm | ||
|---|---|---|
| BGR Government Affairs | $430K | 6 quarters |
| Akin Gump Strauss Hauer & Feld | $260K | 2 quarters |
| King & Spalding | $210K | 9 quarters |
Former officials lobbying for it
| Former position | ||
|---|---|---|
| BRENT ALAN DEL MONTE | Leg. Dir. Rep. Bliley; Sen. Counsel House Energy & Commerce Committee | Q1 2026 |
| CHRIS KELLY | Health Policy Dir., Leg. Asst., Leg. Corr., Front Office Coordinator, Staff Asst. Sen. Blackburn | Q1 2026 |
| JOEL D. BAILEY | COS Rep. Panetta; LD Rep. Ashford; LD Rep. Matheson; Sr. LA Rep. Matsui; LA, Sr. LA Rep. Baron Hill; Intern Rep. Rahall | Q1 2026 |
| RAGHAV AGGARWAL | Health Insurance Specialist, CMS; Senior Health Advisor (Detailee), Senate Finance Committee/Sen. Ron Wyden; Social Science Research Analyst, CMS; Intern, Sen. Feinstein; Secretarys Fellow, US Dept. of Interior | Q1 2026 |
Lobbying reports
| Filed by | ||
|---|---|---|
| 07/20for Q2 | BGR Government Affairs | Under $5,000 |
| 07/20for Q2 | Akin Gump Strauss Hauer & Feld | $130K |
| 04/20for Q1 | BGR Government Affairs | $40K |
| 04/20for Q1 | Akin Gump Strauss Hauer & Feld | $130K |
| 03/30for Q1 | Akin Gump Strauss Hauer & Feld | Under $5,000 |
| 01/20for Q4 2025 | BGR Government Affairs | $110K |
| 25/10/20for Q3 2025 | BGR Government Affairs | $110K |
| 25/07/21for Q2 2025 | BGR Government Affairs | $110K |
| 25/04/21for Q1 2025 | BGR Government Affairs | $60K |
| 25/04/10for Q1 2025 | BGR Government Affairs | Under $5,000 |
| 25/01/14for Q4 2024 | King & Spalding | Under $5,000 |
| 24/10/20for Q3 2024 | King & Spalding | Under $5,000 |
| 24/07/21for Q2 2024 | King & Spalding | $10K |
| 24/04/19for Q1 2024 | King & Spalding | $90K |
| 24/01/16for Q4 2023 | King & Spalding | $20K |
| 23/10/16for Q3 2023 | King & Spalding | $50K |
| 23/07/11for Q2 2023 | King & Spalding | $40K |
| 23/04/18for Q1 2023 | King & Spalding | Under $5,000 |
| 23/01/18for Q4 2022 | King & Spalding | Under $5,000 |